Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Upshaw-Schulman Syndrome”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04683003
What this trial is testing

TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Takeda 77
Not applicableLooking for participantsNCT01257269
What this trial is testing

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

Who this might be right for
Thrombotic Thrombocytopenic PurpuraCongenital Thrombotic Thrombocytopenic PurpuraFamilial Thrombotic Thrombocytopenic Purpura+2 more
Insel Gruppe AG, University Hospital Bern 450
Not applicableNot Yet RecruitingNCT07429942
What this trial is testing

Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Takeda 94
Not applicableLooking for participantsNCT06441578
What this trial is testing

A Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Takeda 40
Not applicableStudy completedNCT03519672
What this trial is testing

Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP]

Who this might be right for
Congenital Thrombotic Thrombocytopenic Purpura
Baxalta now part of Shire 41
Not applicableApproved For MarketingNCT05770219
What this trial is testing

Expanded Access Program of TAK-755 for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Takeda
Post-approval studies (Phase 4)WithdrawnNCT01754545
What this trial is testing

Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura

Who this might be right for
Purpura, Thrombotic Thrombocytopenic
St. Olavs Hospital
Not applicableLooking for participantsNCT07353099
What this trial is testing

A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Takeda 50
Large-scale testing (Phase 3)Study completedNCT03393975
What this trial is testing

BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Baxalta now part of Shire 52
Testing effectiveness (Phase 2)Ended earlyNCT00726544
What this trial is testing

Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy

Who this might be right for
Thrombotic MicroangiopathyThrombotic Thrombocytopenic Purpura
Archemix Corp. 100
Not applicableWithdrawnNCT02626663
What this trial is testing

The Role of Microparticles as a Biomarker

Who this might be right for
Atypical Hemolytic Uremic SyndromeThrombotic Thrombocytopenic PurpuraMicroparticles+1 more
University of Rochester